Les antécédents de cancer augmentent-ils le risque de TSGI ?
Oui, des antécédents de cancers digestifs peuvent augmenter le risque de développer des TSGI.
Antécédents de cancerFacteurs de risqueTumeurs stromales gastro-intestinales
#5
Le stress a-t-il un impact sur le développement des TSGI ?
Aucune preuve solide ne lie le stress au développement des TSGI, mais il peut affecter la santé globale.
StressSantéTumeurs stromales gastro-intestinales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs stromales gastro-intestinales : Questions médicales les plus fréquentes",
"headline": "Tumeurs stromales gastro-intestinales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs stromales gastro-intestinales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-23",
"dateModified": "2026-07-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs stromales gastro-intestinales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs gastro-intestinales",
"url": "https://questionsmedicales.fr/mesh/D005770",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs gastro-intestinales",
"code": {
"@type": "MedicalCode",
"code": "D005770",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.405.249"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs stromales gastro-intestinales",
"alternateName": "Gastrointestinal Stromal Tumors",
"code": {
"@type": "MedicalCode",
"code": "D046152",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "César Serrano",
"url": "https://questionsmedicales.fr/author/C%C3%A9sar%20Serrano",
"affiliation": {
"@type": "Organization",
"name": "Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Toshirou Nishida",
"url": "https://questionsmedicales.fr/author/Toshirou%20Nishida",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, National Cancer Center Hospital, Chuoku, Tokyo, Japan. tnishida@ncc.go.jp."
}
},
{
"@type": "Person",
"name": "Chandrajit P Raut",
"url": "https://questionsmedicales.fr/author/Chandrajit%20P%20Raut",
"affiliation": {
"@type": "Organization",
"name": "Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Jonathan C Trent",
"url": "https://questionsmedicales.fr/author/Jonathan%20C%20Trent",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA."
}
},
{
"@type": "Person",
"name": "Ronald P DeMatteo",
"url": "https://questionsmedicales.fr/author/Ronald%20P%20DeMatteo",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Incidence and Survival Outcomes of Gastrointestinal Stromal Tumors.",
"datePublished": "2024-08-01",
"url": "https://questionsmedicales.fr/article/39158910",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.28828"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37755158",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medsci11030054"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gastrointestinal Stromal Tumors: Variants and Some Pitfalls That They Create.",
"datePublished": "2024-09-04",
"url": "https://questionsmedicales.fr/article/39466697",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PAP.0000000000000463"
}
},
{
"@type": "ScholarlyArticle",
"name": "Isolated liver gastrointestinal stromal tumor: A case report.",
"datePublished": "2024-06-22",
"url": "https://questionsmedicales.fr/article/39367697",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcu.23746"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pilot Study by Liquid Biopsy in Gastrointestinal Stromal Tumors: Analysis of",
"datePublished": "2024-06-20",
"url": "https://questionsmedicales.fr/article/38928487",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25126783"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies gastro-intestinales",
"item": "https://questionsmedicales.fr/mesh/D005767"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs gastro-intestinales",
"item": "https://questionsmedicales.fr/mesh/D005770"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs stromales gastro-intestinales",
"item": "https://questionsmedicales.fr/mesh/D046152"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs stromales gastro-intestinales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs stromales gastro-intestinales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs stromales gastro-intestinales",
"description": "Comment diagnostique-t-on une TSGI ?\nQuels examens sont utilisés pour détecter les TSGI ?\nQuels marqueurs tumoraux sont associés aux TSGI ?\nLes TSGI peuvent-elles être confondues avec d'autres tumeurs ?\nQuel rôle joue l'endoscopie dans le diagnostic des TSGI ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs stromales gastro-intestinales",
"description": "Quels sont les symptômes courants des TSGI ?\nLes TSGI provoquent-elles des symptômes précoces ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes TSGI peuvent-elles causer une perte de poids ?\nLes symptômes des TSGI varient-ils selon leur localisation ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs stromales gastro-intestinales",
"description": "Peut-on prévenir les TSGI ?\nLes antécédents familiaux augmentent-ils le risque de TSGI ?\nY a-t-il des habitudes de vie à éviter pour réduire le risque ?\nLes examens réguliers aident-ils à détecter les TSGI ?\nLes TSGI sont-elles liées à des infections ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs stromales gastro-intestinales",
"description": "Quel est le traitement principal des TSGI ?\nLes TSGI répondent-elles à la chimiothérapie ?\nQuel rôle joue l'imatinib dans le traitement des TSGI ?\nPeut-on traiter les TSGI par radiothérapie ?\nY a-t-il des traitements expérimentaux pour les TSGI ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs stromales gastro-intestinales",
"description": "Quelles complications peuvent survenir avec les TSGI ?\nLes TSGI peuvent-elles récidiver après traitement ?\nComment les TSGI affectent-elles la qualité de vie ?\nLes TSGI peuvent-elles entraîner des métastases ?\nQuelles sont les conséquences d'une obstruction intestinale due aux TSGI ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs stromales gastro-intestinales",
"description": "Quels sont les principaux facteurs de risque des TSGI ?\nL'âge influence-t-il le risque de TSGI ?\nLes TSGI sont-elles plus fréquentes chez un sexe particulier ?\nLes antécédents de cancer augmentent-ils le risque de TSGI ?\nLe stress a-t-il un impact sur le développement des TSGI ?",
"url": "https://questionsmedicales.fr/mesh/D046152#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une TSGI ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie, la biopsie et l'analyse génétique."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour détecter les TSGI ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens incluent l'échographie, la tomodensitométrie et l'IRM."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux TSGI ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le gène c-KIT et la protéine CD117 sont des marqueurs clés."
}
},
{
"@type": "Question",
"name": "Les TSGI peuvent-elles être confondues avec d'autres tumeurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être confondues avec des tumeurs bénignes ou d'autres sarcomes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'endoscopie dans le diagnostic des TSGI ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'endoscopie permet de visualiser les lésions et de réaliser des biopsies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des TSGI ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, saignements et obstructions intestinales."
}
},
{
"@type": "Question",
"name": "Les TSGI provoquent-elles des symptômes précoces ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les symptômes apparaissent tardivement, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent survenir même si la tumeur est petite ou non détectée."
}
},
{
"@type": "Question",
"name": "Les TSGI peuvent-elles causer une perte de poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur et l'obstruction peuvent entraîner une perte de poids significative."
}
},
{
"@type": "Question",
"name": "Les symptômes des TSGI varient-ils selon leur localisation ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la localisation influence les symptômes, comme des douleurs spécifiques ou des saignements."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les TSGI ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour les TSGI."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque de TSGI ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de syndromes génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à éviter pour réduire le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain peut aider, mais il n'y a pas de lien direct établi."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à détecter les TSGI ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers peuvent aider à détecter des anomalies, mais pas spécifiquement les TSGI."
}
},
{
"@type": "Question",
"name": "Les TSGI sont-elles liées à des infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, aucune infection n'est clairement liée à l'apparition des TSGI."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des TSGI ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est le traitement principal, visant à retirer la tumeur complètement."
}
},
{
"@type": "Question",
"name": "Les TSGI répondent-elles à la chimiothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement résistantes à la chimiothérapie, mais des thérapies ciblées peuvent aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imatinib dans le traitement des TSGI ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imatinib est un traitement ciblé efficace pour les TSGI avec mutation c-KIT."
}
},
{
"@type": "Question",
"name": "Peut-on traiter les TSGI par radiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est rarement utilisée, mais peut être envisagée dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour les TSGI ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent de nouvelles thérapies ciblées et immunothérapies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les TSGI ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements, des obstructions et des métastases."
}
},
{
"@type": "Question",
"name": "Les TSGI peuvent-elles récidiver après traitement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive, surtout si la tumeur n'est pas complètement retirée."
}
},
{
"@type": "Question",
"name": "Comment les TSGI affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent causer des douleurs chroniques et des limitations fonctionnelles."
}
},
{
"@type": "Question",
"name": "Les TSGI peuvent-elles entraîner des métastases ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les TSGI peuvent se propager à d'autres organes, notamment le foie et les poumons."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une obstruction intestinale due aux TSGI ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une obstruction peut entraîner des douleurs sévères, des vomissements et nécessiter une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des TSGI ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des syndromes génétiques comme le syndrome de Carney et le syndrome de von Recklinghausen."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de TSGI ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les TSGI sont plus fréquentes chez les adultes, généralement entre 50 et 70 ans."
}
},
{
"@type": "Question",
"name": "Les TSGI sont-elles plus fréquentes chez un sexe particulier ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles touchent les deux sexes, mais certaines études suggèrent une légère prévalence chez les hommes."
}
},
{
"@type": "Question",
"name": "Les antécédents de cancer augmentent-ils le risque de TSGI ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancers digestifs peuvent augmenter le risque de développer des TSGI."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le développement des TSGI ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune preuve solide ne lie le stress au développement des TSGI, mais il peut affecter la santé globale."
}
}
]
}
]
}
Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publications dans "Tumeurs stromales gastro-intestinales" :
The incidence of gastrointestinal stromal tumors (GISTs) increased after the implementation of GIST-specific histology coding in 2001, but updated data on trends and survival are lacking....
To examine the evolving epidemiology of GISTs in major organ sites....
This descriptive, population-based cohort study used nationally representative data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program, including the SEER-22...
Organ site-specific trends in age-standardized incidence rates and annual percent changes (APCs) in rates were estimated by race and ethnicity and, when possible, by sex, age, and primary indicator. M...
The SEER-22 and SEER-17 datasets contained 23 001 and 12 109 case patients with GISTs, respectively. Patients in the SEER-22 registry had a mean (SD) age of 64 (13) years and 51.3% were men. With rega...
In this cohort study using SEER data, the incidence of GISTs in major organ sites increased in the last 2 decades among several population groups. These findings suggest that additional studies are wa...
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract (GIT) that represent approximately 1 to 2 percent of primary gastrointestinal (GI) cancers. Owing t...
Our study comprised 2374 patients diagnosed with GISTs from 2000 to 2017 from the Surveillance, Epidemiology, and End Results (SEER) database. We analyzed the baseline characteristics, and overall mor...
Multivariate Cox proportional hazard regression analyses of factors affecting the all-cause mortality and GIST-related mortality among US patients between 2010 and 2017 revealed a higher overall morta...
In this updated study on the outcomes of patients with GISTs, we found that non-Hispanic Black patients, male patients, and patients older than 60 years have a higher mortality with GISTs. Furthermore...
The diagnosis of gastrointestinal stromal tumors (GISTs) is generally straightforward using a combination of histologic evaluation and pertinent immunohistochemical staining with CD117/kit and DOG-1 (...
Gastrointestinal stromal tumors (GISTs) originate from the gastrointestinal tract. GISTs originate outside the gastrointestinal tract, referred to as extra GISTs, which is rare. Primary liver gastroin...
Tissue biopsy remains the standard for diagnosing gastrointestinal stromal tumors (GISTs), although liquid biopsy is emerging as a promising alternative in oncology. In this pilot study, we advocate f...
Epithelioid gastrointestinal stromal tumors (GISTs) are rare and may be confused with other tumors with epithelioid morphology. Therefore, herein, we collected 12 epithelioid GIST samples and summariz...
Due to the increasing recognition of gastrointestinal stromal tumor (GIST), novel insights have appeared in both preclinical and clinical research and begun to reshape the field. This study aims to ma...
We searched the Web of Science Core Collection without publication data restrictions for GISTs and performed a bibliometric analysis with CiteSpace and VOSviewer software....
In sum, 5,911 of 13,776 records were included, and these studies were published in 948 journals and written by 24,965 authors from 4,633 institutions in 100 countries. Referring to published reviews a...
Potential hotspots in future GIST trends might involve epidemiology, agents, resection therapy and rare type GIST, moreover, researchers could pay more attention in these four fields....
Due to the lack of corresponding clinical symptoms, small calcified gastric gastrointestinal stromal tumors (GISTs) are often overlooked in clinical practice. Therefore, there is an unmet need to defi...
The medical records (gastroscopy, pre-treatment gastric CT imaging [pre- and post-contrast scans], pathology) of patients with calcified gastric GISTs < 1 cm in diameter confirmed pathologically after...
Seven patients had 8 calcified gastric GISTs < 1 cm in diameter. Six patients hadsingle lesions, and 1patients had multiple lesions. Six patients had lesions in the gastric fundus, 1 patient had a les...
Novel CT features of gastric GISTs included: commonly found in the gastric antrum, small size (< 1 cm in diameter), calcification, few solid soft tissue components, and no abnormal enhancement in most...
Children, adolescents, and young adults (CAYA) (age ≤39 years) with GIST have high rates of LNM, but their clinical relevance is undefined. This study analyzed the impact of LNM on overall survival (O...
The National Cancer Database was queried for patients with resected GIST and pathologic nodal staging data from 2004-2019. Factors associated with LNM were identified. Survival was assessed stratified...
Of 4420 patients with GIST, 238 were CAYA (5.4%). When compared to older adults, CAYA more often had small intestine primaries (51.8% vs. 36.6%, p < 0.0001), T4 tumors (30.7% vs. 24.5%, p = 0.0275) an...
LNM are more commonly identified among CAYA with resected GIST who undergo lymph node evaluations, but do not appear to impact OS as observed in older adults. High mitotic rate remains a predictor of ...
Due to rarity of duodenal GISTs, clinicians have few information about its clinical features, diagnosis, management and prognosis....
We report a case of promptly diagnosed duodenal GIST in a 61-year-old Egyptian man presented shocked with severe attack of hematemesis and melena. Upper gastroduodenal endoscopy was done and revealed ...
despite being rare, emergency presentation with sudden severe, life-threatening hemorrhagic shock duodenal GISTs might be a cause of potentially lethal massive combined upper and lower gastrointestina...
